IC50:12 µM (CDK2)[1].
CDK2-IN-13 (Compound 15) is a cancer[1].
[1]. HavlÍcek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12.
















